Senior Medical Science Liaison

If you are unable to complete this application due to a disability, contact this employer to ask for an accommodation or an alternative application process. Full Time Cambridge, Cambridge, MA, US Salary Range: $220,000.00 To $270,000.00 Annually ABOUT IMMUNEERING Immuneering Corporation (Nasdaq: IMRX) is a clinical-stage biopharmaceutical company developing oncology therapies using its proprietary Deep Cyclic Inhibition platform. Our lead asset, atebimetinib (IMM-1-104), is an oral, once-daily Deep Cyclic Inhibitor of MEK in active Phase 2 and Phase 3 (MAPKeeper 301) clinical trials in pancreatic cancer and RAS-mutant non-small cell lung cancer, as well as additional solid tumor programs. We are committed to delivering transformative treatments to patients with limited options through rigorous science and a collaborative, mission-driven culture. POSITION SUMMARY This is a foundational hire. As Immuneering’s first US-based field medical employee, this role will establish the company’s scientific presence with key opinion leaders and academic oncology centers nationwide. This role is best suited for a senior MSL who is willing to engage with KOLs enthusiastically and build a rapport with the scientific community, with the strategic vision and potential to grow into a leadership position within a lean, mission-driven organization. The selected MSL may have the opportunity to assist with the company’s international MSL buildout across Western Europe, Central-Eastern Europe, and the Australia/APAC region, and could quickly step into the role of Field Medical Director. US Field Medical Affairs Develop and manage peer-to-peer scientific relationships with oncology KOLs, academic investigators, and institutional stakeholders at priority centers including MSKCC, City of Hope, OHSU, and the SCRI/USON/OneOncology networks and others. As a major priority, this individual will support investigator identification and engagement for MAPKeeper 301 Phase 3 enrollment; facilitate site activation and scientific readiness at high-enrolling centers. Deliver accurate, balanced, and compliant scientific exchange on Immuneering’s Deep Cyclic Inhibition mechanism, MAPKeeper in metastatic pancreatic cancer, atebimetinib + cemiplimab in RAS-mutant NSCLC and other possible studies related to the MAPK pathway. Respond to unsolicited medical information requests from healthcare professionals in accordance with FDA guidelines on scientific exchange. Generate and communicate field insights — including HCP perspectives, competitive intelligence, and clinical practice patterns — to Medical Affairs, Clinical, and Commercial stakeholders. Provide flexible US territory coverage (East, Central/South, West) based on enrollment priorities and KOL geography. Represent Immuneering at national and regional oncology congresses (possibly including ASCO, AACR, ESMO and others). Partner with Medical Affairs leadership to develop scientific messaging frameworks, training curricula, and field activity standards for the global consultant network. May quickly transform into a leadership position as the Field Medical Director, which would entail managing the buildout of Immuneering’s OUS consultant MSL network across the UK/Western Europe, Central-Eastern Europe (Poland, Czech Republic, Hungary, Romania), and Australia/APAC. Contribute to MSL infrastructure, SOPs, and reporting frameworks as Immuneering scales toward commercialization or partnership. Education Advanced degree in a health science discipline (MD, PharmD, PhD, or MSN/NP/PA with oncology specialization) 3–5+ years of MSL experience in oncology; prior experience at a biotech or clinical-stage company strongly preferred Technical / Soft Skills Required Established KOL relationships in pancreatic cancer, thoracic oncology, or a closely adjacent tumor type Deep understanding of clinical trial design, oncology drug development, and FDA-compliant scientific exchange Ability to translate complex mechanistic science (RAS/MAPK pathway biology, adaptive resistance, combination strategies) for diverse oncology audiences Willingness and ability to travel 50–60% domestically; occasional international travel for global team alignment and congresses US-based; eligible to work in the United States without sponsorship Preferred Background in RAS/MEK pathway biology, GI oncology, or thoracic oncology Experience supporting Phase 2 or Phase 3 clinical trial enrollment as an MSL Prior experience in a lead MSL, field medical director, or senior leadership field medical role Familiarity with medical affairs operations in an international or multi-regional context Experience working with or coordinating medical affairs consultants or CRO-based MSL models EQUAL OPPORTUNITY EMPLOYER Immuneering Corporation is an equal opportunity employer. We celebrate diversity and are committed to creating an inclusive environment for all employees. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, disability, protected veteran status, or any other characteristic protected by law. #J-18808-Ljbffr